Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder
NPC1 leads to difficulty controlling movements, liver and lung disease, impaired swallowing, intellectual decline and death.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Genetics | Liver | National Institutes of Health (NIH) | Urology & Nephrology